Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer

Immunogenic cell death (ICD) can be exploited to treat non-immunoreactive tumors that do not respond to current standard and innovative therapies. Not all chemotherapeutics trigger ICD, among those that do exert this effect, there are anthracyclines, irinotecan, some platinum derivatives and oncolyt...

Descrición completa

Detalles Bibliográficos

Principais autores:	Alessandro Rencinai, Eva Tollapi, Giulia Marianantoni, Jlenia Brunetti, Tania Henriquez, Alessandro Pini, Luisa Bracci, Chiara Falciani
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-10-01
Series:	Frontiers in Molecular Biosciences
Assuntos:	immunogenic cell death pancreatic cancer oncolytic peptides danger associated molecular patterns metastasis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fmolb.2024.1429163/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!